J&J Medical Connect
Neuroscience
Neuroscience

Congress Materials – American Society of Clinical Psychopharmacology (ASCP 2025)

 

2025 American Society of Clinical Psychopharmacology | May 27-30 | Scottsdale, AZ

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses.  Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

 

Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From an Additional Randomized, Double-Blind, Phase 3 Trial

Willie R. Earley, Suresh Durgam, Susan G. Kozauer, Yifan Mo, Hassan Lakkis, Renee Rotolo, Susan G. Kornstein, Maurizio Fava

View poster

Efficacy and Safety of Esketamine Nasal Spray as Monotherapy in Adults With Treatment-Resistant Depression Based on Oral Antidepressant Status at Study Entry: A Post Hoc Analysis

Andrew J Cutler, Dong-Jing Fu, Ibrahim Turkoz, Patricia Cabrera, Oliver Lopena, Lisa Lim, Muhammad Ahmed, Dillon McGovern

View poster

Long-Term Adjunctive Lumateperone Treatment in Major Depressive Disorder: Results From a Six-Month Open-Label Extension Study

Willie R. Earley, Suresh Durgam, Susan G. Kozauer, Changzheng Chen, Tobie Escher, Andrew J. Cutler

View poster

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress

Suresh Durgam, Willie R. Earley, Susan G. Kozauer, Changzheng Chen, Dennis Sholler, Gary S. Sachs

View poster

Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-blind, Phase 3 Trial

Suresh Durgam, Willie R. Earley, Susan G. Kozauer, Changzheng Chen, Hassan Lakkis, Margaret Martin, Roger S. McIntyre, Stephen Stahl

View poster

Prescriber and Patient-Level Characteristics Associated With Adherence to Antipsychotics Among Patients With Schizophrenia in the United States

Arthur Voegel, Ronaldo R Naranjo Jr, Lilian Diaz, Claire Vanden Eynde, Yuxi Wang, Charmi Patel, Dominic Pilon, Carmela Benson, Leslie Citrome

View poster

 

Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.